Guardant Health, Inc. (GH) stock
GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$143.28−0.75 (-0.52%)
Close on Nov 17, 2026Market cap $19.23BP/E –Yield –
Guardant Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Guardant Health's operating cash flow for the twelve months ending Jun 30, 2026 was -$185.19M. For fiscal 2025 it was -$184.76M. The highest annual figure on record is -$36.71M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$184.76M | – |
| FY2024 | Dec 31, 2024 | -$239.86M | – |
| FY2023 | Dec 31, 2023 | -$324.98M | – |
| FY2022 | Dec 31, 2022 | -$309.46M | – |
| FY2021 | Dec 31, 2021 | -$209.02M | – |
| FY2020 | Dec 31, 2020 | -$103.93M | – |
| FY2019 | Dec 31, 2019 | -$47.13M | – |
| FY2018 | Dec 31, 2018 | -$72.19M | – |
| FY2017 | Dec 31, 2017 | -$72.24M | – |
| FY2016 | Dec 31, 2016 | -$36.71M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$57.78M | – |
| Q1 FY2026 | Mar 31, 2026 | -$65.62M | – |
| Q4 FY2025 | Dec 31, 2025 | -$26.37M | – |
| Q3 FY2025 | Sep 30, 2025 | -$35.41M | – |
| Q2 FY2025 | Jun 30, 2025 | -$60.29M | – |
| Q1 FY2025 | Mar 31, 2025 | -$62.69M | – |
| Q4 FY2024 | Dec 31, 2024 | -$64.51M | – |
| Q3 FY2024 | Sep 30, 2024 | -$51.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$94.00M | – |
| Q1 FY2024 | Mar 31, 2024 | -$30.28M | – |
| Q4 FY2023 | Dec 31, 2023 | -$78.73M | – |
| Q3 FY2023 | Sep 30, 2023 | -$77.79M | – |
| Q2 FY2023 | Jun 30, 2023 | -$94.02M | – |
| Q1 FY2023 | Mar 31, 2023 | -$74.44M | – |
| Q4 FY2022 | Dec 31, 2022 | -$90.75M | – |
| Q3 FY2022 | Sep 30, 2022 | -$78.16M | – |
| Q2 FY2022 | Jun 30, 2022 | -$111.94M | – |
| Q1 FY2022 | Mar 31, 2022 | -$28.62M | – |
| Q4 FY2021 | Dec 31, 2021 | -$76.99M | – |
| Q3 FY2021 | Sep 30, 2021 | -$53.15M | – |
| Q2 FY2021 | Jun 30, 2021 | -$62.59M | – |
| Q1 FY2021 | Mar 31, 2021 | -$16.29M | – |
| Q4 FY2020 | Dec 31, 2020 | -$59.22M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.06M | -698.1% |
| Q2 FY2020 | Jun 30, 2020 | -$23.37M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.28M | – |
| Q4 FY2019 | Dec 31, 2019 | -$30.34M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.35M | – |
| Q2 FY2019 | Jun 30, 2019 | -$13.84M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.30M | – |
| Q4 FY2018 | Dec 31, 2018 | -$26.54M | – |
| Q3 FY2018 | Sep 30, 2018 | -$22.05M | – |
| Q2 FY2018 | Jun 30, 2018 | -$17.04M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.56M | – |
| Q4 FY2017 | Dec 31, 2017 | -$17.99M | – |
See a number that looks wrong?